Pay in 4 interest-free payments of $5.71 Learn more
Ships within 48 hours · Estimated delivery Sep 3 - Sep 8
BPC-157 is not approved by the Therapeutic Goods Administration (TGA) and is prohibited by the World Anti-Doping Agency (WADA)
Researchers have described this as the compounds key differentiating feature in systematic reviews of the preclinical literature
Bobbi Horne, Vice President Healthcare Professional Division at Max International, reiterated the company's dedication to scientific research and meeting consumer expectations, stating that "we see it as an obligation to the consumer to produce supplements with the highest quality ingredients, in formulations that work." Study design: The double-blinded, placebo-controlled human clinical trial was approved by the University of Santa Catarina Ethics Committee and involved 40 participants aged 38 to 60
All content and information provided are for educational and research reference purposes only
